(NASDAQ: AWH) Aspira Women's Health's forecast annual revenue growth rate of 16.89% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 2.42%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.29%.
Aspira Women's Health's revenue in 2024 is $9,154,000.On average, 1 Wall Street analysts forecast AWH's revenue for 2024 to be $132,081,913, with the lowest AWH revenue forecast at $132,081,913, and the highest AWH revenue forecast at $132,081,913.
In 2025, AWH is forecast to generate $164,176,583 in revenue, with the lowest revenue forecast at $164,176,583 and the highest revenue forecast at $164,176,583.